Lidds AB (LIDDS) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.413x

Based on the latest financial reports, Lidds AB (LIDDS) has a cash flow conversion efficiency ratio of -0.413x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-616.00K ≈ $-66.29K USD) by net assets (Skr1.49 Million ≈ $160.56K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Lidds AB (LIDDS) balance sheet quality index to measure how much of total assets are equity-financed.

Lidds AB - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Lidds AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Lidds AB to evaluate the quality of earnings relative to operating cash generation.

Lidds AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Lidds AB ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
MEDCAW INVESTMENTS LS-01 F:U09	N/A
Wildpack Beverage Inc V:CANS	0.068x
Israel Opportunity - Energy Resources LP TA:ISOP-L	-0.055x
NATURENERGIE SW:NEAG	0.064x
Reco International Group Inc V:RGI	0.037x
Wheeler Real Estate Investment Trust, Inc. NASDAQ:WHLR	0.049x
Pebble Beach Systems Group PLC LSE:PEB	0.760x
BLUERUSH Media Group Corp V:BTV	-0.015x

Annual Cash Flow Conversion Efficiency for Lidds AB (2013–2024)

The table below shows the annual cash flow conversion efficiency of Lidds AB from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see LIDDS market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Skr6.18 Million ≈ $664.96K	Skr-5.43 Million ≈ $-584.68K	-0.879x	+53.39%
2023-12-31	Skr13.90 Million ≈ $1.50 Million	Skr-26.22 Million ≈ $-2.82 Million	-1.886x	+18.65%
2022-12-31	Skr15.35 Million ≈ $1.65 Million	Skr-35.59 Million ≈ $-3.83 Million	-2.319x	-163.81%
2021-12-31	Skr48.51 Million ≈ $5.22 Million	Skr-42.64 Million ≈ $-4.59 Million	-0.879x	-37.23%
2020-12-31	Skr42.81 Million ≈ $4.61 Million	Skr-27.42 Million ≈ $-2.95 Million	-0.641x	-470.12%
2019-12-31	Skr152.13 Million ≈ $16.37 Million	Skr-17.09 Million ≈ $-1.84 Million	-0.112x	-1131.42%
2018-12-31	Skr158.52 Million ≈ $17.06 Million	Skr-1.45 Million ≈ $-155.64K	-0.009x	+89.16%
2017-12-31	Skr127.25 Million ≈ $13.69 Million	Skr-10.71 Million ≈ $-1.15 Million	-0.084x	-352.72%
2016-12-31	Skr112.52 Million ≈ $12.11 Million	Skr-2.09 Million ≈ $-225.21K	-0.019x	+74.68%
2015-12-31	Skr99.77 Million ≈ $10.74 Million	Skr-7.33 Million ≈ $-788.75K	-0.073x	-3.47%
2014-12-31	Skr96.37 Million ≈ $10.37 Million	Skr-6.84 Million ≈ $-736.33K	-0.071x	-1.37%
2013-12-31	Skr75.21 Million ≈ $8.09 Million	Skr-5.27 Million ≈ $-566.87K	-0.070x	--

About Lidds AB

ST:LIDDS Sweden Biotechnology

Market Cap

$361.27K

Skr3.36 Million SEK

Market Cap Rank

#31021 Global

#732 in Sweden

Share Price

Skr0.02

Change (1 day)

+0.00%

52-Week Range

Skr0.01 - Skr0.09

All Time High

Skr19.64